Watch Ticker

Soleno Therapeutics, Inc. Common Stock

Go to Soleno Therapeutics, Inc. Common Stock Website

$84.12

0.00 (0.00%)

Live

Previous Close

$84.12

Day Range

$0 - $0

Previous Day Range

$83.965 - $87.19

Market Cap

$4.5 billion USD

Day Vol.

Previous Day Vol.

721528

Currency

USD

Primary Exchange

Nasdaq

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a cryst...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Brian Ritchie, Lifesci Advisors, Llc - Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025

Soleno Therapeutics reported preliminary Q2 2025 financial results, with expected net revenue of $31-33 million for VYKATTM XR, approximately $293.8 million in cash, and 646 patient start forms from 295 unique prescribers since product approval.

Related tickers: SLNO.

Read Full Article

N/A - Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

Soleno Therapeutics announced the validation of its Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for its drug Diazoxide Choline Prolonged-Release Tablets (DCCR) to treat hyperphagia in Prader-Willi syndrome patients.

Related tickers: SLNO.

Read Full Article

Trending Tickers

Please sign in to view